Caesalpinia bonducella (L.) Fleming, also known as Caesalpinia bonduc (L.) Roxb. and Caesalpinia crista Linn., belongs to the family Caesalpiniaceae. It is a spiny shrub found worldwide, particularly in India, Sri Lanka, and the Andaman and Nicobar Islands, thriving mainly in tropical regions. This plant is highly valued in traditional medicine due to its therapeutic properties, with all parts being utilized for medicinal purposes.
It has been reported to exhibit a wide range of pharmacological activities, including anxiolytic, antinociceptive, antidiarrheal, antidiabetic, adaptogenic, anthelmintic, antiestrogenic, anti-inflammatory, antimalarial, antimicrobial, antifungal, antispasmodic, antioxidant, antiproliferative, antipsoriatic, antitumor, larvicidal, muscle contractile, hepatoprotective, anticonvulsant, and antifilarial effects.
Phytochemical analysis of its seeds has identified the presence of various bioactive compounds such as alkaloids, flavonoids, glycosides, saponins, tannins, and triterpenoids.
Introduction
Medicinal plants are vital in global healthcare for treating diseases and maintaining wellness, with their therapeutic effects linked to specific bioactive compounds extracted by various methods. Many pharmaceutical drugs originate from plant extracts, which are used for conditions like cardiovascular, liver, neurological, and metabolic disorders.
Caesalpinia bonducella Overview
Scientific Classification: Belongs to the Fabaceae family, widely found in tropical regions including India and Sri Lanka.
Physical Description: A thorny shrub with bipinnate leaves, pale yellow flowers, spiny pods, and distinctive gray, eyeball-like seeds known as "Kuberakshi" in Sanskrit.
Bioactive Components: Contains alkaloids, flavonoids, glycosides, saponins, tannins, and triterpenoids.
Traditional Names: Known as Karanjwa in Unani medicine and has various names in Ayurveda, Siddha, and vernacular languages.
Medicinal Uses and Pharmacology
Used traditionally to treat inflammation, fever, boils, malaria, skin diseases, hydrocele, and leprosy.
Pharmacological properties include anxiolytic, antinociceptive, antidiarrheal, antifilarial, antiviral, antibacterial, antidiabetic, anti-inflammatory, antioxidant, and immunomodulatory effects.
Seed kernels are employed as tonics, febrifuges, and in treating convulsions, paralysis, and respiratory issues.
Recognized in Ayurveda and Unani medicine for managing tumors, cysts, asthma, and various infections.
Caesalpinia bonducella and PCOS
Effective in managing Polycystic Ovary Syndrome (PCOS), a hormonal disorder in women involving ovarian dysfunction and metabolic symptoms.
Traditionally, decoctions and pastes from the seeds are used for respiratory and skin ailments.
Traditional Preparations and Applications
Seeds used externally for boils and swellings, internally for fever, liver disorders, and digestive problems.
Used as a dentifrice for gum ailments.
Mixed with other herbs and substances in various Ayurvedic and Unani formulations.
Powdered seed kernels are part of classical remedies for orchitis, ovaritis, and scrofula.
Habitat and Distribution
Grows in hedges, forests, plains, and sacred groves.
Distributed across tropical regions globally and cultivated as a hedge plant.
Conclusion
The significant nutraceutical potential of this plant, owing to its effectiveness and versatility, highlights the need for further in-depth research. Acute toxicity studies have confirmed its safety for human consumption, making it suitable for use in commercial nutraceutical formulations. Additionally, the plant exhibits a range of pharmacological effects across various diseases and conditions, establishing it as a valuable asset for the Indian nutraceutical industry.
References
[1] Veerapandiyan Kandasamy, Usha Balasundaram, “Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS):A review” ;Journal of Ethnopharmacology 2021, 279 ; 114375 ;2-16
[2] Sambasivam Manikandaselvi, Vellingiri Vadivel2* and Pemaiah Brindha2; Caesalpinia bonducella L.: A nutraceutical plant; Journal of Chemical and Pharmaceutical Research, 2015, 7(12):137-142
[3] Dayanand M. Kannur, Mukta P. Paranjpe1, Lalit V. Sonavane2, Prerana P. Dongre, Kishanchand R. Khandelwal, Evaluation of Caesalpinia bonduc seed coat extract for anti-inflammatory and analgesic activity, Journal of Advanced Pharmaceutical Technology &Research, 2012, 3(3) 171-175
[4] Vigasini Subbiah, Pannaga Nagaraja, Priya Narayan*, Holenarasipur Gundu Rao Nagendra;Evaluation of Pharmacological Properties of Caesalpinia bonducella Seed and Shell Extract; Pharmacognosy Journal, 2019, 11(1) :150-154
[5] Desh Deepak Pandey, Alok Pal Jain and Abhay Kumar; Caesalpinia bonducella : A pharmacological important plant; The Pharma Innovation Journal 2018; 7(12) 190-193
[6] Kanchan R. Salunke, R. Nazeer Ahmed *,Shambanagouda R. Marigoudar and Lilaram; Effectof graded doses of Caesalpinia bonducella seed extract on ovary and uterus in albino rats; J Basic Clin PhysiolPharmacol 2011;22(1-2):49–53.
[7] SS Handa; MK Kaul. Supplement to cultivation and utilization of medicinal plants. RRL, Jammu-Tawi, 1996, 727-37.
[8] K Nazeerullah; S Sunil; S Rishi Pal; D Neelam. Res J Pharm Biol Chem Sci., 2012, 3(1), 480-96.
[9] N Muruganantham; KH Basavaraj; SP Dhanabal; TK Praveen; NM Shamasundar; KS Rao. J Ethnopharmacol., 2011, 133(2), 897-901.
[10] A Jabbar; AZ Muhammad; I Zafar; M Yaseen; A Shamim. J Ethnopharmacol., 2007, 114(1), 86-91.
[11] V Singh; PK Raghav. Int J Med Arom Plant., 2012, 2(3), 514-30.
[12] Manikandaselvi S, Vadivel V, Brindha P. Caesalpinia bonducella L. A nutraceutical plant. Journal of Chemical and Pharmaceutical Research. 2015;7(12):137-42.
[13] Kannur DM, Paranjpe MP, Sonavane LV, Dongre PP, Khandelwal KR. Evaluation of Caesalpinia bonduc seed coat extract for anti-inflammatory and analgesic. J Adv Pharm Technol Res. 2012;3(3):171-5.
[14] Khare CP. Indian Medicinal Plants: An Illustrated Dictionary. New York: Springer Science+ Business Media. 2007;107-8.
[15] The Wealth of India: A Dictionary of Indian Raw Materials and Industrial Products; Raw Materials and Industrial Products, Part II. In “C.” B. N. Sastri. New Delhi, India: Council of Scientific and Industrial Research. 1950;2:1951.
[16] Ghatak NG. Chemical examination of kernals of the seeds of Caesalpinia bonducella. Proc Indian Acad Sci. 1934;4:141.
[17] Iyenger MA, Pendse GS. Anti-diarrheal activity of the nuts of Caesalpinia bonducella Flem. Indian J Phar. 1965;27:307.
[18] Tummin KMC. Chemical examination of seeds of CaesaipiniabonducellaFiem.8. J Indian Chem Soc. 1930;7:207.
[19] Chopra RN, Chopra IC, Verma BS. Supplement to Glossary of Indian Medicinal Plants, Publication and Information Directorate (CSIR), New Delhi. 1969.
[20] Vedavyasa S, Ahamad RN. Antihyperlipidemic Effect of Alcoholic Seed Extract of Caesalpinia BonducIn Alloxan Induced Diabetic Male Albino Rats. International Journal of Diabetic and Endocrinology. 2015;4(1):1-9.
[21] Antoni J. Duleba, M.D.,a and Anuja Dokras, Is PCOS an inflammatory process?; ElsevierInc;October 12, 2011; 7-12.
[22] R. Jeffrey Chang, MD, A practical approach to the diagnosis of polycystic ovary syndrome,American , Journal of Obstetrics and Gynecology (2004) 191, 713–717
[23] Poli Mara Spritzer, Polycystic ovary syndrome: reviewing diagnosis and management ofmetabolic disturbances, Nov 2013, http://dx.doi.org/10.1590/0004-2730000003051
[24] 24.Valentina Rodriguez Paris and Michael J. Bertoldo, The Mechanism of Androgen Actions inPCOS Etiology, MDPI, 2019, 2-12
[25] Evanthia Diamanti-Kandarakis, Asimina Mitrakou, Magda M.I. Hennes, DimitrisPlatanissiotis, Nicholas Kaklas, Jovanna Spina, Elli Georgiadou, Raymond G. Hoffmann,Ahmed H. Kissebah, and Sotos Raptis, Insulin Sensitivity and Antiandrogenic Therapy in
[26] Women WithPolycystic Ovary Syndrome, Metabolism, 1955, 44(4), 525-531
[27] World Health Organisation,” Poly Cystic Ovarian Syndrome” , June, 2023www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome.